Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2021-07-06 00:00:00 ET · period of report 2021-07-01 · accession 0001209191-21-045571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-06 | 2021-07-01 | GMED | Pfeil Keith W | SVP, CFO | M - OptEx | $53.27 | +833 | 833 | New | +$44.4K |
| D | 2021-07-06 | 2021-07-01 | GMED | Pfeil Keith W | SVP, CFO | S - Sale+OE | $77.43 | -833 | 0 | -100% | -$64.5K |
| D | 2021-07-06 | 2021-07-01 | GMED | Pfeil Keith W | SVP, CFO | M - OptEx | $0.00 | -833 | 25.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-01 | M | A | 833 | $53.27 | 833 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-07-01 | S | D | 833 | $77.43 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2021-07-01 | M | D | 833 | $0.00 | 25,000 | D | $53.27 · — to 2030-01-22 | 833 Class A Common Stock | (F2) These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |